Bio-Techne's Acquisition of Lunaphore Expands Its Spatial Biology Offerings
Portfolio Pulse from Vandana Singh
Bio-Techne Corporation (NASDAQ:TECH) has agreed to acquire Lunaphore Inc, a Swiss company that develops automated spatial biology solutions. The acquisition is expected to close in Q1 of Bio-Techne's fiscal 2024 and will expand its spatial biology offerings, providing automation for RNAscope assays and synergies with its antibody portfolio.
June 22, 2023 | 2:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bio-Techne's acquisition of Lunaphore will expand its spatial biology offerings and provide automation for RNAscope assays, potentially boosting its market position.
The acquisition of Lunaphore will expand Bio-Techne's spatial biology offerings, providing automation for RNAscope assays and synergies with its antibody portfolio. This could lead to increased market share and revenue for the company, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100